title: Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants.
abstract: OBJECTIVE
  We sought to determine if an association exists between the use of histamine-2 receptor (H2) blockers and the incidence of necrotizing enterocolitis (NEC) in infants of 401 to 1500 g in birth weight.
  
  
  METHODS
  Data from the National Institute of Child Health and Human Development Neonatal Research Network very low birth weight (401-1500 g) registry from September 1998 to December 2001 were analyzed. The relation between the diagnosis of NEC (Bell stage II or greater) and antecedent H2-blocker treatment was determined by using case-control methodology. Conditional logistic regression was implemented, controlling for gender, site of birth (outborn versus inborn), Apgar score of < 7 at 5 minutes, and postnatal steroids.
  
  
  RESULTS
  Of 11072 infants who survived for at least 12 hours, 787 (7.1%) developed NEC (11.5% of infants 401-750 g, 9.1% of infants 751-1000 g, 6.0% of infants 1001-1250 g, and 3.9% of infants 1251-1500 g). Antecedent H2-blocker use was associated with an increased incidence of NEC (P < .0001).
  
  
  CONCLUSIONS
  H2-blocker therapy was associated with higher rates of NEC, which is in agreement with a previous randomized trial of acidification of infant feeds that resulted in a decreased incidence of NEC. In combination, these data support the hypothesis that gastric pH level may be a factor in the pathogenesis of NEC.
authors.affiliation: Division of Neonatology, Department of Pediatrics, University of Rochester, Rochester, New York, USA. ronnie_guillet@urmc.rochester.edu
authors.forename: Ronnie
authors.initials: R
authors.lastname: Guillet
authors.forename: Barbara J
authors.initials: BJ
authors.lastname: Stoll
authors.forename: C Michael
authors.initials: CM
authors.lastname: Cotten
authors.forename: Marie
authors.initials: M
authors.lastname: Gantz
authors.forename: Scott
authors.initials: S
authors.lastname: McDonald
authors.forename: W Kenneth
authors.initials: WK
authors.lastname: Poole
authors.forename: Dale L
authors.initials: DL
authors.lastname: Phelps
mesh_terms: D016022:Case-Control Studies; D020345:Enterocolitis, Necrotizing / Q000139:chemically induced*; D005260:Female; D006635:Histamine H2 Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D019102:Infant, Very Low Birth Weight; D008297:Male
chemical_list: D006635:Histamine H2 Antagonists